#ITI#Pandemic H1N1 influenza virus in chilean commercial turkeys with genetic and serologic comparisons to U.S. H1N1 avian influenza vaccine isolates#FTI#
#IRE#Beginning in April 2009, a novel H1N1 influenza virus caused acute respiratory disease in humans, first in Mexico and then around the world. The resulting pandemic influenza A H1N1 2009 (pH1N1) virus was isolated in swine in Canada in June 2009 and later in breeder turkeys in Chile, Canada, and the United States. The pH1N1 virus consists of gene segments of avian, human, and swine influenza origin and has the potential for infection in poultry following exposure to infected humans or swine. We examined the clinical events following the initial outbreak of pH1N1 in turkeys and determined the relatedness of the hemagglutinin (HA) gene segments from the pH1N1 to two H1N1 avian influenza (AI) isolates used in commercial turkey inactivated vaccines. Overall, infection of turkey breeder hens with pH1N1 resulted in ≥50% reduction of egg production over 34 weeks. Genetic analysis indicated one H1N1 AI vaccine isolate (A/turkey/North Carolina/17026/1988) contained approximately 92% nucleotide sequence similarity to the pH1N1 virus (A/Mexico/4109/2009); whereas, a more recent AI vaccine isolate (A/swine/North Carolina/00573/2005) contained 75.9% similarity. Comparison of amino acids found at antigenic sites of the HA protein indicated conserved epitopes at the Sa site; however, major differences were found at the Ca2 site between pH1N1 and A/turkey/North Carolina/127026/1988. Hemagglutinin-inhibition (HI) tests were conducted with sera produced in vaccinated turkeys in North Carolina to determine if protection would be conferred using U.S. AI vaccine isolates. HI results indicate positive reactivity (HI titer ≥ 5 log2) against the vaccine viruses over the course of study. However, limited cross-reactivity to the 2009 pH1N1 virus was observed, with positive titers in a limited number of birds (6 out of 20) beginning only after a third vaccination. Taken together, these results demonstrate that turkeys treated with these vaccines would likely not be protected against pH1N1 and current vaccines used in breeder turkeys in the United States against circulating H1N1 viruses should be updated to ensure adequate protection against field exposure. © 2011 American Association of Avian Pathologists.#FRE#
#IPC#avian influenza virus; hemagglutinin; immunology; pandemic H1N1; turkeys; vaccines#FPC#
#IRF#Brownlee G.G., Fodor E., The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin, Philosophical Transactions of the Royal Society B: Biological Sciences, 356, 1416, pp. 1871-1876, (2001); 
Caton A.J., Brownlee G.G., Yewdell J.W., Gerhard W., The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype), Cell, 31, 2, pp. 417-427, (1982); 
Choi Y.K., Lee J.H., Erickson G., Goyal S.M., Joo H.S., Webster R.G., Webby R.J., H3N2 influenza virus transmission from swine to turkeys, United States, Emerging Infectious Diseases, 10, 12, pp. 2156-2160, (2004); 
Cohen J., Pandemic influenza Straight from the pig's mouth: Swine research with swine influenzas, Science, 325, pp. 140-141, (2009); 
Dawood F.S., Jain S., Finelli L., Shaw M.W., Lindstrom S., Garten R.J., Gubareva L.V., Xu X., Bridges C.B., Uyeki T.M., Emergence of a novel swine-origin influenza A (H1N1) virus in humans, N. Engl. J. Med., 360, pp. 2605-2615, (2009); 
Elbers A.R.W., Koch G., Bouma A., Performance of clinical signs in poultry for the detection of outbreaks during the avian influenza A (H7N7) epidemic in the Netherlands in 2003, Avian Pathology, 34, 3, pp. 181-187, (2005); 
Gamblin S.J., Haire L.F., Russell R.J., Stevens D.J., Xiao B., Ha Y., Vasisht N., Steinhauer D.A., Daniels R.S., Elliot A., Wiley D.C., Skehel J.J., The structure and receptor binding properties of the 1918 influenza hemagglutinin, Science, 303, 5665, pp. 1838-1842, (2004); 
Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., Sessions W.M., Xu X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C.B., Emery S.L., Hillman M.J., Rivailler P., Smagala J., De Graaf M., Burke D.F., Fouchier R.A., Pappas C., Alpuche-Aranda C.M., Lopez-Gatell H., Olivera H., Lopez I., Myers C.A., Faix D., Blair P.J., Yu C., Keene K.M., Dotson Jr. P.D., Boxrud D., Sambol A.R., Abid S.H., St. George K., Bannerman T., Moore A.L., Stringer D.J., Blevins P., Demmler-Harrison G.J., Ginsberg M., Kriner P., Waterman S., Smole S., Guevara H.F., Belongia E.A., Clark P.A., Beatrice S.T., Donis R., Katz J., Finelli L., Bridges C.B., Shaw M., Jernigan D.B., Uyeki T.M., Smith D.J., Klimov A.I., Cox N.J., Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans, Science, 325, pp. 197-201, (2009); 
Gerhard W., Yewdell J., Frankel M.E., Webster R., Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies, Nature, 290, 5808, pp. 713-717, (1981); 
Ito T., Interspecies transmission and receptor recognition of influenza A viruses, Microbiology and Immunology, 44, 6, pp. 423-430, (2000); 
Ito T., Couceiro J.N.S.S., Kelm S., Baum L.G., Krauss S., Castrucci M.R., Donatelli I., Kida H., Paulson J.C., Webster R.G., Kawaoka Y., Molecular basis for the generation in pigs of influenza A viruses with pandemic potential, Journal of Virology, 72, 9, pp. 7367-7373, (1998); 
Ito T., Kawaoka Y., Host-range barrier of influenza A viruses, Veterinary Microbiology, 74, 1-2, pp. 71-75, (2000); 
Kapczynski D.R., Gonder E., Liljebjelke K., Lippert R., Petkov D., Tilley B., Vaccine-induced protection from egg production losses in commercial turkey breeder hens following experimental challenge with a triple-reassortant H3N2 avian influenza virus, Avian Dis., 53, pp. 7-15, (2009); 
Kapczynski D.R., Swayne D.E., Influenza vaccines for avian species, Curr. Top. Microbiol. Immunol., 333, pp. 133-152, (2009); 
Kuiken T., Holmes E.C., McCauley J., Rimmelzwaan G.F., Williams C.S., Grenfell B.T., Host species barriers to influenza virus infections, Science, 312, pp. 394-397, (2006); 
Liljebjelke K.A., Petkov D.I., Kapczynski D.R., Mucosal vaccination with a codon-optimized hemagglutinin gene expressed by attenuated Salmonella elicits a protective immune response in chickens against highly pathogenic avian influenza, Vaccine, 28, pp. 4430-4437, (2010); 
Manicassamy B., Medina R.A., Hai R., Tsibane T., Stertz S., Nistal-Villan E., Palese P., Basler C.F., Garcia-Sastre A., Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines, PLoS Pathog., 6, (2010); 
Mathieu C., Moreno V., Retamal P., Gonzalez A., Rivera A., Fuller J., Jara C., Lecocq C., Rojas M., Garcia A., Vasquez M., Agredo M., Gutierrez C., Escobar H., Fasce R., Mora J., Garcia J., Fernandez J., Ternicier C., Avalos P., Pandemic (H1N1) 2009 in breeding turkeys, Valparaiso, Chile, Emerg. Infect. Dis., 16, pp. 709-711, (2010); 
Matrosovich M., Tuzikov A., Bovin N., Gambaryan A., Klimov A., Castrucci M.R., Donatelli I., Kawaoka Y., Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals, Journal of Virology, 74, 18, pp. 8502-8512, (2000); 
Olsen C.W., Carey S., Hinshaw L., Karasin A.I., Virologic and serologic surveillance for human, swine and avian influenza virus infections among pigs in the north-central United States, Arch. Virol., 145, pp. 1399-1419, (2000); 
Pantin-Jackwood M., Wasilenko J.L., Spackman E., Suarez D.L., Swayne D.E., Susceptibility of turkeys to pandemic-H1N1 virus by reproductive tract insemination, Virol. J., 7, (2010); 
Rogers G.N., Paulson J.C., Daniels R.S., Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity, Nature, 304, 5921, pp. 76-78, (1983); 
Suarez D.L., Lee C.W., Swayne D.E., Avian influenza vaccination in North America: Strategies and difficulties, Developments in Biologicals, 124, pp. 117-124, (2006); 
Suarez D.L., Spackman E., Senne D.A., Update on molecular epidemiology of H1, H5, and H7 influenza virus infections in poultry in North America, Avian Diseases, 47, SPEC. ISS., pp. 888-897, (2003); 
Suarez D.L., Woolcock P.R., Bermudez A.J., Senne D.A., Isolation from turkey breeder hens of a reassortant H1N2 influenza virus with swine, human, and avian lineage genes, Avian Diseases, 46, 1, pp. 111-121, (2002); 
Swayne D.E., Garcia M., Beck J.R., Kinney N., Suarez D.L., Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert, Vaccine, 18, pp. 1088-1095, (2000); 
Swayne D.E., Halverson D.A., Influenza, Diseases of Poultry, pp. 135-160, (2003); 
Swayne D.E., Kapczynski D., Strategies and challenges for eliciting immunity against avian influenza virus in birds, Immunol. Rev., 225, pp. 314-331, (2008); 
Swayne D.E., Lee C.W., Spackman E., Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus, Avian Pathol., 35, pp. 141-146, (2006); 
Swayne D.E., Pantin-Jackwood M., Kapczynski D., Spackman E., Suarez D.L., Susceptibility of poultry to pandemic (H1N1) 2009 virus, Emerg. Infect. Dis., 15, pp. 2061-2063, (2009); 
Tamura K., Nei M., Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees, Molecular Biology and Evolution, 10, 3, pp. 512-526, (1993); 
Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S., MEGA5: Molecular evolutionary genetics analysis using maximum likelihood evolutionary distance and maximum parsimony methods, Mol. Biol. Evol., (2011); 
Tang Y., Lee C.W., Zhang Y., Senne D.A., Dearth R., Byrum B., Perez D.R., Suarez D.L., Saif Y.M., Isolation and characterization of H3N2 influenza A virus from turkeys, Avian Diseases, 49, 2, pp. 207-213, (2005); 
Terregino C., De Nardi R., Nisi R., Cilloni F., Salviato A., Fasolato M., Capua I., Resistance of turkeys to experimental infection with an early 2009 Italian human influenza A(H1N1)v virus isolate, Euro. Surveill., 14, (2009); 
Tumpey T.M., Kapczynski D.R., Swayne D.E., Comparative susceptibility of chickens and turkeys to avian influenza A H7N2 virus infection and protective efficacy of a commercial avian influenza H7N2 virus vaccine, Avian Diseases, 48, 1, pp. 167-176, (2004); 
Underwood P.A., Mapping of antigenic changes in the haemagglutinin of Hong Kong influenza (H3N2) strains using a large panel of monoclonal antibodies, Journal of General Virology, 62, 1, pp. 153-169, (1982); 
Vincent A.L., Ma W., Lager K.M., Gramer M.R., Richt J.A., Janke B.H., Characterization of a newly emerged genetic cluster of H1N1 and H1N2 swine influenza virus in the United States, Virus Genes, 39, pp. 176-185, (2009); 
Wan H., Perez D.R., Quail carry sialic acid receptors compatible with binding of avian and human influenza viruses, Virology, 346, 2, pp. 278-286, (2006); 
Wiley D.C., Wilson I.A., Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation, Nature, 289, 5796, pp. 373-378, (1981); 
Wilson I.A., Cox N.J., Structural basis of immune recognition of influenza virus hemagglutinin, Annual Review of Immunology, 8, pp. 737-771, (1990); 
Yassine H.M., Al-Natour M.Q., Lee C.W., Saif Y.M., Interspecies and intraspecies transmission of triple reassortant H3N2 influenza A viruses, Virol. J., 4, (2007); 
Yassine H.M., Lee C.W., Suarez D.L., Saif Y.M., Genetic and antigenic relatedness of H3 subtype influenza A viruses isolated from avian and mammalian species, Vaccine, 26, pp. 966-977, (2008); 
Yewdell J.W., Monoclonal antibodies specific for discontinuous epitopes direct refolding of influenza A virus hemagglutinin, Mol. Immunol., 47, pp. 1132-1136, (2010); 
Zhou N.N., Senne D.A., Landgraf J.S., Swenson S.L., Erickson G., Rossow K., Liu L., Yoon K.-J., Krauss S., Webster R.G., Genetic reassortment of avian, swine, and human influenza A viruses in American pigs, Journal of Virology, 73, 10, pp. 8851-8856, (1999); 
Zhou N.N., Senne D.A., Landgraf J.S., Swenson S.L., Erickson G., Rossow K., Liu L., Yoon K.-J., Krauss S., Webster R.G., Emergence of H3N2 reassortant influenza A viruses in North American pigs, Veterinary Microbiology, 74, 1-2, pp. 47-58, (2000)#FRF#
